Kingstone's Reinsurance Program: Why it is a Cornerstone of Growth

Kingstone Companies (KINS) has significantly bolstered its 2025/2026 catastrophe reinsurance program, increasing its limit by 57% to $440 million, which includes a new $125 million catastrophe bond. This expanded coverage was secured with only a 10% cost increase, lowering the total cat cover cost to 12% of projected premiums and is anticipated to boost H2 2025 earnings by $0.11. The enhanced program is a core driver of KINS's growth strategy, improving capital efficiency and enabling premium expansion, underscoring disciplined risk management despite the stock's year-to-date underperformance and its valuation exceeding industry averages.

Analysis

Kingstone Companies (KINS) has substantially fortified its risk management framework by increasing its 2025/2026 catastrophe reinsurance limit by 57% to $440 million. This significant expansion of coverage, which includes a new $125 million catastrophe bond, was achieved with only a 10% increase in cost, effectively lowering the reinsurance cost as a percentage of projected direct premiums from 13% to 12%. The improved efficiency is expected to directly benefit the bottom line, with a projected boost of 11 cents to earnings per share in the second half of 2025. This enhanced program is not merely a defensive measure but a cornerstone of Kingstone's growth strategy; by ceding approximately 25% of its personal lines premiums via quota share treaties, the company improves its combined ratio, enhances capital efficiency, and supports premium growth, as evidenced by the over 20% expansion in its core New York market last year. Despite these positive fundamental developments, KINS's market performance and valuation present a mixed picture. The stock has underperformed its industry year-to-date with a marginal 0.4% gain and trades at a premium valuation with a price-to-book ratio of 2.59, well above the industry average of 1.55. While consensus earnings estimates for 2025 and 2026 have remained static over the past 30 days, projections for revenue and EPS still indicate year-over-year growth.

Key Decisions for Investors

• Investors should recognize the new reinsurance program as a material positive catalyst, significantly de-risking the balance sheet and enhancing capital efficiency for future premium growth.
• It is critical to weigh the company's high price-to-book valuation of 2.59 against the industry average of 1.55 and its recent stock underperformance before initiating or adding to a position.
• Monitor for upward revisions in 2025 and 2026 earnings estimates, as the current consensus has not moved in 30 days and may not yet factor in the 11-cent EPS boost and improved combined ratio.